carmustine has been researched along with Cyst in 8 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carmustine wafers can be implanted in the surgical bed of high-grade gliomas, which can induce surgical bed cyst formation, leading to clinically relevant mass effect." | 8.12 | Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas. ( Ammar, H; Baroud, M; Benevello, C; Benzakoun, J; Chretien, F; Dezamis, E; Dhermain, F; Moiraghi, A; Oppenheim, C; Pallud, J; Parraga, E; Peeters, S; Roux, A; Varlet, P; Zah-Bi, G; Zanello, M, 2022) |
| "To retrospectively determine the safety and efficacy of combined chemotherapy with carmustine (BCNU) wafer, bevacizumab, and temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma (GBM)." | 7.88 | Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience. ( Akiyama, Y; Enatsu, R; Kimura, Y; Mikami, T; Mikuni, N; Wanibuchi, M, 2018) |
| "The development of perifocal edema and tumor bed cyst has been reported after implantation of biodegradable carmustine wafers for the treatment of malignant gliomas." | 7.83 | The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema. ( Hasegawa, Y; Iuchi, T; Kawasaki, K; Sakaida, T; Yokoi, S, 2016) |
| "Carmustine wafers can be implanted in the surgical bed of high-grade gliomas, which can induce surgical bed cyst formation, leading to clinically relevant mass effect." | 4.12 | Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas. ( Ammar, H; Baroud, M; Benevello, C; Benzakoun, J; Chretien, F; Dezamis, E; Dhermain, F; Moiraghi, A; Oppenheim, C; Pallud, J; Parraga, E; Peeters, S; Roux, A; Varlet, P; Zah-Bi, G; Zanello, M, 2022) |
| "To retrospectively determine the safety and efficacy of combined chemotherapy with carmustine (BCNU) wafer, bevacizumab, and temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma (GBM)." | 3.88 | Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience. ( Akiyama, Y; Enatsu, R; Kimura, Y; Mikami, T; Mikuni, N; Wanibuchi, M, 2018) |
| "The development of perifocal edema and tumor bed cyst has been reported after implantation of biodegradable carmustine wafers for the treatment of malignant gliomas." | 3.83 | The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema. ( Hasegawa, Y; Iuchi, T; Kawasaki, K; Sakaida, T; Yokoi, S, 2016) |
| "The hypodense, roughly spherical cysts clearly demonstrated clinically significant mass effect, and required reoperation despite treatment with high-dose corticosteroids." | 1.31 | Tumor bed cyst formation after BCNU wafer implantation: report of two cases. ( Engelhard, HH, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Roux, A | 1 |
| Ammar, H | 1 |
| Moiraghi, A | 1 |
| Peeters, S | 1 |
| Baroud, M | 1 |
| Zah-Bi, G | 1 |
| Benzakoun, J | 1 |
| Parraga, E | 1 |
| Oppenheim, C | 1 |
| Benevello, C | 1 |
| Chretien, F | 1 |
| Varlet, P | 1 |
| Dhermain, F | 1 |
| Dezamis, E | 1 |
| Zanello, M | 1 |
| Pallud, J | 1 |
| Akiyama, Y | 1 |
| Kimura, Y | 1 |
| Enatsu, R | 1 |
| Mikami, T | 1 |
| Wanibuchi, M | 1 |
| Mikuni, N | 1 |
| Grangeon, L | 1 |
| Ferracci, FX | 1 |
| Fetter, D | 1 |
| Maltete, D | 1 |
| Langlois, O | 1 |
| Gilard, V | 1 |
| Nakase, K | 1 |
| Matsuda, R | 1 |
| Nishimura, F | 1 |
| Nakamura, M | 1 |
| Motoyama, Y | 1 |
| Park, YS | 1 |
| Nakase, H | 1 |
| Hasegawa, Y | 1 |
| Iuchi, T | 1 |
| Sakaida, T | 1 |
| Yokoi, S | 1 |
| Kawasaki, K | 1 |
| Engelhard, HH | 1 |
| McGirt, MJ | 1 |
| Villavicencio, AT | 1 |
| Bulsara, KR | 1 |
| Friedman, HS | 1 |
| Friedman, AH | 1 |
| Persson, L | 1 |
| Boethius, J | 1 |
| Gronowitz, JS | 1 |
| Källander, C | 1 |
| Lindgren, L | 1 |
8 other studies available for carmustine and Cyst
| Article | Year |
|---|---|
Discriminating surgical bed cysts from bacterial brain abscesses after Carmustine wafer implantation in newly diagnosed IDH-wildtype glioblastomas.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Abscess; Brain Neoplasms; Carmustine; Cysts; Gliobla | 2022 |
Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; B | 2018 |
How safe are carmustine wafers?
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cysts; Drug Implants; Glioblastoma; | 2018 |
[A Case of Symptomatic Cyst Formation after BCNU Wafer Implantation for Glioblastoma].
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cysts; Fe | 2015 |
The influence of carmustine wafer implantation on tumor bed cysts and peritumoral brain edema.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Carmustine; Cysts; Female; Gl | 2016 |
Tumor bed cyst formation after BCNU wafer implantation: report of two cases.
Topics: Antineoplastic Agents, Alkylating; Brain Diseases; Brain Neoplasms; Carmustine; Chemotherapy, Adjuva | 2000 |
Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Biopsy; Brain | 2002 |
Thymidine kinase in brain-tumor cysts.
Topics: Brain Neoplasms; Carmustine; Cysts; Glioma; Humans; Thymidine Kinase | 1985 |